Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Shortened intensified multi-agent chemotherapy and non-cross resistant maintenance therapy for advanced lymphoblastic lymphoma in children and adolescents: report from the Children's Oncology Group.

Abromowitch M, Sposto R, Perkins S, Zwick D, Siegel S, Finlay J, Cairo MS; Children's Oncology Group.

Br J Haematol. 2008 Oct;143(2):261-7. doi: 10.1111/j.1365-2141.2008.07320.x. Epub 2008 Aug 28.

2.

Chromosome abnormalities in advanced stage lymphoblastic lymphoma of children and adolescents: a report from CCG-E08.

Lones MA, Heerema NA, Le Beau MM, Sposto R, Perkins SL, Kadin ME, Kjeldsberg CR, Meadows A, Siegel S, Buckley J, Abromowitch M, Kersey J, Bergeron S, Cairo MS, Sanger WG.

Cancer Genet Cytogenet. 2007 Jan 1;172(1):1-11.

PMID:
17175373
3.

NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth.

Palomero T, Lim WK, Odom DT, Sulis ML, Real PJ, Margolin A, Barnes KC, O'Neil J, Neuberg D, Weng AP, Aster JC, Sigaux F, Soulier J, Look AT, Young RA, Califano A, Ferrando AA.

Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18261-6. Epub 2006 Nov 17. Erratum in: Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4240.

4.

Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc.

Sharma VM, Calvo JA, Draheim KM, Cunningham LA, Hermance N, Beverly L, Krishnamoorthy V, Bhasin M, Capobianco AJ, Kelliher MA.

Mol Cell Biol. 2006 Nov;26(21):8022-31. Epub 2006 Sep 5.

5.

c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma.

Weng AP, Millholland JM, Yashiro-Ohtani Y, Arcangeli ML, Lau A, Wai C, Del Bianco C, Rodriguez CG, Sai H, Tobias J, Li Y, Wolfe MS, Shachaf C, Felsher D, Blacklow SC, Pear WS, Aster JC.

Genes Dev. 2006 Aug 1;20(15):2096-109. Epub 2006 Jul 17. Erratum in: Genes Dev. 2007 Mar 1;21(5):625.

6.

Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast.

Graux C, Cools J, Michaux L, Vandenberghe P, Hagemeijer A.

Leukemia. 2006 Sep;20(9):1496-510. Epub 2006 Jul 6. Review.

PMID:
16826225
7.

Molecular cytogenetic study of 126 unselected T-ALL cases reveals high incidence of TCRbeta locus rearrangements and putative new T-cell oncogenes.

Cauwelier B, Dastugue N, Cools J, Poppe B, Herens C, De Paepe A, Hagemeijer A, Speleman F.

Leukemia. 2006 Jul;20(7):1238-44. Epub 2006 May 4.

PMID:
16673021
8.

Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.

Raetz EA, Perkins SL, Bhojwani D, Smock K, Philip M, Carroll WL, Min DJ.

Pediatr Blood Cancer. 2006 Aug;47(2):130-40.

PMID:
16358311
9.

Molecular genetics of acute lymphoblastic leukemia.

Armstrong SA, Look AT.

J Clin Oncol. 2005 Sep 10;23(26):6306-15. Review.

PMID:
16155013
10.

Genetic insights in the pathogenesis of T-cell acute lymphoblastic leukemia.

De Keersmaecker K, Marynen P, Cools J.

Haematologica. 2005 Aug;90(8):1116-27. Review.

11.

The TCL1 family of oncoproteins: co-activators of transformation.

Teitell MA.

Nat Rev Cancer. 2005 Aug;5(8):640-8. Review. Erratum in: Nat Rev Cancer. 2005 Sep;5(9):750.

PMID:
16056259
12.

Childhood and adolescent non-Hodgkin lymphoma: new insights in biology and critical challenges for the future.

Cairo MS, Raetz E, Lim MS, Davenport V, Perkins SL.

Pediatr Blood Cancer. 2005 Nov;45(6):753-69. Review.

PMID:
15929129
13.

Advances in the diagnostic approach to childhood lymphoblastic malignant neoplasms.

Reddy KS, Perkins SL.

Am J Clin Pathol. 2004 Dec;122 Suppl:S3-18. Review.

PMID:
15690639
14.

Skp2-dependent degradation of p27kip1 is essential for cell cycle progression.

Kossatz U, Dietrich N, Zender L, Buer J, Manns MP, Malek NP.

Genes Dev. 2004 Nov 1;18(21):2602-7.

15.

Expression of P53 and bcl-2 proteins in T-cell lymphoblastic lymphoma: prognostic implications.

Naresh KN, Banavali SD, Bhatia KG, Magrath I, Soman CS, Advani SH.

Leuk Lymphoma. 2002 Feb;43(2):333-7.

PMID:
11999565
16.

BCL-6 protein is expressed in precursor T-cell lymphoblastic lymphoma and in prenatal and postnatal thymus.

Hyjek E, Chadburn A, Liu YF, Cesarman E, Knowles DM.

Blood. 2001 Jan 1;97(1):270-6.

17.

New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases.

Schneider NR, Carroll AJ, Shuster JJ, Pullen DJ, Link MP, Borowitz MJ, Camitta BM, Katz JA, Amylon MD.

Blood. 2000 Oct 1;96(7):2543-9.

18.

Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia.

Kawamura M, Ohnishi H, Guo SX, Sheng XM, Minegishi M, Hanada R, Horibe K, Hongo T, Kaneko Y, Bessho F, Yanagisawa M, Sekiya T, Hayashi Y.

Leuk Res. 1999 Feb;23(2):115-26.

PMID:
10071127
19.

Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer Group.

Heerema NA, Sather HN, Sensel MG, Kraft P, Nachman JB, Steinherz PG, Lange BJ, Hutchinson RS, Reaman GH, Trigg ME, Arthur DC, Gaynon PS, Uckun FM.

J Clin Oncol. 1998 Apr;16(4):1270-8.

PMID:
9552025
20.

The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations.

Villuendas R, Piris MA, Algara P, Sánchez-Beato M, Sánchez-Verde L, Martinez JC, Orradre JL, García P, Lopez C, Martinez P.

Blood. 1993 Nov 15;82(10):3151-6.

Items per page

Supplemental Content

Write to the Help Desk